Most states allow some form of "medical marijuana". Medical marijuana is especially popular with pain patients, many of whom ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

Despite an increase in the use of medication for opioid use disorder in older adults from 2017 to 2022, disparities persist; ...

Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical ...

Navega is pursuing a radically different approach for treatment of chronic pain associated with rare diseases and other common intractable chronic pain conditions such primary erythromelalgia and ...

Algiax Pharmaceuticals, a clinical-stage biotech company focused on developing innovative treatments for chronic neuropathic pain, today announced compelling topline data from its Phase 2a clinical ...

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

Your feet are the foundation of your entire body, and when they're not healthy, it can affect your overall well-being and ...

Adolore BioTherapeutics (”Adolore” or the “Company”), is developing intracellularly-delivered neuromodulators that naturally reduce neuronal excitability to restore balance to the PNS/CNS to treat the ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).